https://www.avient.com/sites/default/files/2022-06/Maxxam FR Injection Molding Processing Guide.pdf
Ratio 2.5:1–3.0:1 Nozzle Type General purpose Clamp Pressure (tons/in²) 2–4
https://www.avient.com/sites/default/files/2022-05/Compensation Committee Charter (REV 10-2019).pdf
inclusion in the Company’s proxy statement or other applicable SEC filings. 4
https://www.avient.com/sites/default/files/2020-08/2020-composite-springs-product-selection-install-guide.pdf
st er MECHANICAL PERFORMANCE TESTING NOTES Springs were fatigue tested at 4
https://www.avient.com/sites/default/files/2022-10/PREPERM_for_5G_Application_Bulletin_CN10.8-2.pdf
目标介电常数 -- +/- 2% 3,76 3,78 3,80 3,82 3,84 3,86 3,88 3,90 3,92 3,94 0 1 2 3 4
https://www.avient.com/sites/default/files/2022-07/MEVOPUR Chemical Foaming Agents Application Bulletin_CN.pdf
不得将埃万特的产品用于旨在用于以下目的的任何医疗器械应用： (1) 接触人体组织或体液长达30天或更长时间； (2)“整形”（整容或重建）手术； (3) 生殖植入物或任何节育器械；或者 (4)
https://www.avient.com/sites/default/files/2022-05/MEVOPUR LQ for Silicone Elastomers_CN.pdf
不得将埃万特的产品用于旨在用于以下目的的任何医疗器械应用： (1) 接触人体组织或体液长达30天或更长时间； (2)“整形”（整容或重建）手术； (3) 生殖植入物或任何节育器械；或者 (4)
https://www.avient.com/sites/default/files/2022-07/REMAFIN EP White Masterbatches for Pharma Application Bulletin_CN.pdf
不得将埃万特的产品用于旨在用于以下目的的任何医疗器械应用： (1) 接触人体组织或体液长达30天或更长时间； (2)“整形”（整容或重建）手术； (3) 生殖植入物或任何节育器械；或者 (4)
https://www.avient.com/sites/default/files/resources/TRA%2520-%25202016%2520Plan%2520Summary.pdf
posted for the public File Name * Date * TRA Plan Certifications.pdf 30/04/2018 4:
https://www.avient.com/resource-center/knowledge-base/article/injection-molding-mold-processing
Feb 10, 2025
https://www.avient.com/investor-center/news/polyone-announces-first-quarter-2019-results
Attachment 4